News headlines Vertex Pharmaceuticals (VRTX) is gaining attention with promising developments in kidney treatments and solid earnings growth, although concerns linger about its reliance on cystic ...

EHA: Vertex, CRISPR build case for gene-editing drug A gene-editing drug developed by CRISPR Therapeutics and Vertex Pharma has continued to show impressive results in clinical trial, with an update ...

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...

Abstract: An efficient implicit representation of an n-vertex graph G in a family $\mathcal{F}$ of graphs assigns to each vertex of G a binary code of length O(log n) so that the adjacency between ...

With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly.